Literature DB >> 14961575

Mutation analysis of the MLH1, MSH2 and MSH6 genes in patients with double primary cancers of the colorectum and the endometrium: a population-based study in northern Sweden.

Kristina Cederquist1, Monica Emanuelsson, Ingela Göransson, Elke Holinski-Feder, Yvonne Müller-Koch, Irina Golovleva, Henrik Grönberg.   

Abstract

Hereditary nonpolyposis colorectal cancer (HNPCC) is an autosomal dominant disorder that predisposes to predominantly colorectal and endometrial cancers due to germline mutations in DNA mismatch repair genes, mainly MLH1, MSH2 and in families with excess endometrial cancer also MSH6. In this population-based study, we analysed the mutation spectrum of the MLH1, MSH2 and MSH6 genes in a cohort of patients with microsatellite unstable double primary tumours of the colorectum and the endometrium by PCR, DHPLC and sequencing. Fourteen of the 23 patients (61%) had sequence variants in MLH1, MSH2 or MSH6 that likely affect the protein function. A majority (10/14) of the mutations was found among probands diagnosed before age 50. Five of the mutations (36%) were located in MLH1, 3 (21%) in MSH2 and 6 (43%) in MSH6. MSH6 seem to have larger impact in our population than in other populations, due to a founder effect since all of the MSH6 families originate from the same geographical area. MSH6 mutation carriers have later age of onset of both colorectal cancer (62 vs. 51 years) and endometrial cancer (58 vs. 48 years) and a larger proportion of endometrial cancer than MLH1 or MSH2 mutation carriers. We can conclude that patients with microsatellite unstable double primary cancers of the colorectum and the endometrium have a very high risk of carrying a mutation not only in MLH1 or MSH2 but also in MSH6, especially if they get their first cancer diagnosis before the age of 50. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14961575     DOI: 10.1002/ijc.11718

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  13 in total

1.  CanProVar: a human cancer proteome variation database.

Authors:  Jing Li; Dexter T Duncan; Bing Zhang
Journal:  Hum Mutat       Date:  2010-03       Impact factor: 4.878

2.  Two germline alterations in mismatch repair genes found in a HNPCC patient with poor family history.

Authors:  Enikô Kámory; Miklós Tanyi; Orsolya Kolacsek; Judit Olasz; László Tóth; László Damjanovich; Orsolya Csuka
Journal:  Pathol Oncol Res       Date:  2006-12-25       Impact factor: 3.201

3.  hMLH1 promoter methylation and silencing in primary endometrial cancers are associated with specific alterations in MBDs occupancy and histone modifications.

Authors:  Yuning Xiong; Sean C Dowdy; Norman L Eberhardt; Karl C Podratz; Shi-Wen Jiang
Journal:  Gynecol Oncol       Date:  2006-05-15       Impact factor: 5.482

4.  Screening for Muir-Torre syndrome using mismatch repair protein immunohistochemistry of sebaceous neoplasms.

Authors:  Maegan E Roberts; Douglas L Riegert-Johnson; Brittany C Thomas; Colleen S Thomas; Michael G Heckman; Murli Krishna; David J DiCaudo; Alina G Bridges; Katherine S Hunt; Kandelaria M Rumilla; Mark A Cappel
Journal:  J Genet Couns       Date:  2012-12-06       Impact factor: 2.537

5.  Phenotypic heterogeneity of hereditary gynecologic cancers: a report from the Creighton hereditary cancer registry.

Authors:  Murray Joseph Casey; Chhanda Bewtra; Henry T Lynch; Carrie Snyder; Mark Stacy; Patrice Watson
Journal:  Fam Cancer       Date:  2013-12       Impact factor: 2.375

6.  Lost opportunities for mismatch repair (MMR) screening among minority women with endometrial cancer.

Authors:  Marilyn Huang; Tegan Hunter; Lydia A Fein; Johnny Galli; Sophia George; Matthew Schlumbrecht; Kelly McCarter; Abdulrahman K Sinno; Luiz P Guido; Andre Pinto
Journal:  Sci Rep       Date:  2021-06-03       Impact factor: 4.379

7.  MSH6 syndrome.

Authors:  Janina Suchy; Jan Lubinski
Journal:  Hered Cancer Clin Pract       Date:  2008-06-15       Impact factor: 2.857

8.  Prevalence of pathological germline mutations of hMLH1 and hMSH2 genes in colorectal cancer.

Authors:  Dandan Li; Fulan Hu; Fan Wang; Binbin Cui; Xinshu Dong; Wencui Zhang; Chunqing Lin; Xia Li; Da Wang; Yashuang Zhao
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

9.  MSH6 missense mutations are often associated with no or low cancer susceptibility.

Authors:  R Kariola; H Hampel; W L Frankel; T E Raevaara; A de la Chapelle; M Nyström-Lahti
Journal:  Br J Cancer       Date:  2004-10-04       Impact factor: 7.640

10.  The association between genetic variants in hMLH1 and hMSH2 and the development of sporadic colorectal cancer in the Danish population.

Authors:  Lise Lotte Christensen; Bo E Madsen; Friedrik P Wikman; Carsten Wiuf; Karen Koed; Anne Tjønneland; Anja Olsen; Ann-Christine Syvänen; Claus L Andersen; Torben F Orntoft
Journal:  BMC Med Genet       Date:  2008-06-11       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.